Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 70

Pv-aCO2 gap–guided resuscitation for adults with multiple traumatic injuries

Official title: Evaluation of Effect of Pv-aCO2-Gap on Clinical Outcomes With Standard Resuscitation End-points in Adult Poly-trauma Patients Admitted to the ICU --- Prospective Randomized Control Trial

Run by Pakistan Institute of Medical Sciences · NCT07480655 · Data updated 2026-11-12

This trial will test whether using the difference between venous and arterial carbon dioxide levels to guide resuscitation helps adults with multiple traumatic injuries recover better during ICU care.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment60 (estimated)
SponsorPakistan Institute of Medical Sciences
Government
Locations1 site (Islamabad, Federal)
StatusRecruiting
StartedMarch 16, 2026
Main results expectedJune 16, 2026
Study endsJune 16, 2026
Registry record updatedMarch 18, 2026
Trial IDNCT07480655 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with polytrauma (penetrating or blunt) admitted to the ICU from the operating room, emergency department, or wards who can have central venous and arterial catheters placed and meet the inclusion criteria.

Probably not a fit

Patients with chest trauma, obstructive or restrictive lung disease, obstructive sleep apnea, septic shock, pregnancy, those requiring ECMO, or those expected to be readmitted within 48 hours are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adult polytrauma patients admitted to the ICU are randomized 1:1 to either a Pv-aCO2 gap–targeted resuscitation arm or a control arm managed by conventional resuscitation end points. All participants receive a central venous catheter and an arterial line, with arterial and venous blood gas samples taken within 1 hour of ICU admission and at 6, 12, 24, 48, and 72 hours using a point-of-care analyzer. The intervention arm uses the measured venous-to-arterial CO2 difference to guide hemodynamic management, while the control arm follows standard critical care targets. Results from the serial measurements will be compared to determine whether gap-guided management changes physiological parameters and early clinical course.

Why it matters

Potential benefit: If successful, this approach could help clinicians tailor resuscitation more precisely and potentially reduce organ dysfunction and complications after major trauma.

How similar studies have gone: Observational studies have shown the Pv-aCO2 gap correlates with tissue perfusion and outcomes, but randomized trials of gap-guided resuscitation in trauma patients are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Either Gender
* Poly-trauma patients

  ○ Both penetrating and blunt trauma
* Both surgical and non-surgical
* Shock States

Exclusion Criteria:

* Any Chest trauma
* Patients with Obstructive and restrictive lung disease
* Obstructive sleep apnea
* Septic shock
* Pregnant patients
* Patients who will require readmission within 48 h after step-down from the ICU.
* Patients who will need extra-corporeal membrane oxygenation support

Where it's running

  • Department of Anesthesia, Pakistan Institute of Medical Sciences
    Islamabad, Federal, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.